HCP Training Cartridge – Cue Health (Staging)
Cue® can detect COVID-19 variants BQ.1, BQ1.1, XBB, and XBB.1.5 SHOP TESTS NOW
HCP Training Cartridge
Interested in the Cue Dashboard?
Contact us to purchase the Cue Dashboard or learn more about how our intuitive software can help with data management, analytics, reporting, and more.
Contact Us
Product Details
About the Cue COVID-19 Training Cartridge Pack
Created to help facilitate training and demonstrations, this pack contains 3 Cue COVID-19 Training Cartridges: one generates a positive result, one generates a negative result, and one generates an invalid result. Not for diagnostic use.
How to use the Cue COVID-19 Training Cartridges
The Training Cartridges simulate a diagnostic Cue COVID-19 test — the testing process is almost identical except for sample collection (there is no need to collect a sample). The results will also be returned much faster than a diagnostic COVID-19 test. To use the Training Cartridges, simply follow the step-by-step guide in the Cue Health App.

You can also reference the official Instructions For Use (IFU) for complete details.
Insert the Cartridge into the Reader
Insert the Wand into the cartridge (no need to collect a sample)
Get results from the Cue Health App on your mobile device in 20 minutes
Includes 3 Cue COVID-19 Training Cartridges
  • Package Specifications: 5 x 7 x 0.5 inches; 3.6 oz
  • SKU: 2900009
Documentation & Disclaimers
The Cue COVID-19 Test has not been FDA cleared or approved, but has been authorized by FDA under an Emergency Use Authorization. This product has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens.
Clinical Studies
Cue has participated in or commissioned several clinical studies to demonstrate the safety, efficacy and accuracy of our molecular tests. For study details, see links below.

Independent Mayo Clinic Evaluation of the Cue COVID-19 Test

Cue COVID-19 Test Instructions for Use (IFU)
(Includes Limit of Detection Study, Cross-Reactivity Study, and Prospective Clinical Study in Emergency Departments)
Return Policy
Because Cue has stringent quality assurance requirements as a medical device and product, returns and exchanges are not permitted. See the Cue Terms of Use and End User License Agreement for more details.
Frequently Asked Questions
What professional training is required to administer Cue Tests?
The Cue COVID-19 test is streamlined, easy-to-use, and doesn’t require any specific training to operate.

For directions, conditions of authorization, precautions, and additional information, please see the Cue COVID-19 test Instructions For Use (IFU).

Which payors are currently offering or covering Cue Tests?
As of January 15, 2022, private insurance companies in the United States are required to reimburse their members for COVID-19 tests, per a federal requirement.

Methods and amounts of reimbursement vary by payor, and we encourage you to check with specific payors about their policies regarding reimbursement.

Some providers use 87635 as the CPT code for reimbursement: Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]).

The coding information contained here is for informational purposes only and is not a guarantee of coverage or reimbursement for any product or service. We recommend you consult with your CPT® code advisors for guidance.

What regulatory authorizations have the Cue COVID-19 tests received?
Cue COVID-19 test for CLIA Certified Healthcare Providers and Laboratories
The U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for the Cue COVID-19 test for Professional Use. The Cue COVID-19 test may be used to test symptomatic and asymptomatic individuals for the detection of nucleic acid from SARS-CoV-2. Testing may be performed by CLIA certified laboratories or at the point-of-care (POC), i.e., in patient care settings, operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation

The Cue COVID-19 test for Home and Over The Counter (OTC) Use
The FDA granted the Cue COVID-19 test Emergency Use Authorization (EUA) for Home and Over The Counter (OTC) Use for the detection of nucleic acid from SARS-CoV-2 in symptomatic and asymptomatic individuals, ages 2 years and older. Tests may be purchased without a prescription and self-administered by adults or administered on minors with adult assistance.

What are the FDA requirements for Authorized Laboratories that use the Cue COVID-19 test?
Authorized Laboratories must follow the Cue COVID-19 Test for CLIA Certified Healthcare Providers and Laboratories Instructions For Use. Deviations from the authorized procedures, including authorized clinical specimen types and authorized control materials required to use the Cue COVID-19 Test, are not permitted.

Authorized laboratories must include all authorized fact sheets along with test result reports. Fact sheets for patients and for healthcare providers are available at cuehealth.com/docs.

Authorized laboratories that receive the Cue COVID-19 test must notify the relevant public health authorities of their intent to run the product prior to initiating testing.

Authorized laboratories using the Cue COVID-19 test must have a process in place for reporting test results to healthcare providers and relevant public health authorities, as appropriate.

Authorized laboratories must collect information on the performance of the Cue COVID-19 test and report to DMD/OHT7-OIR/OPEQ/CDRH (via email: CDRH-EUAReporting@fda.hhs.gov) and Cue Health Inc. Technical Support (support@cuehealth.com) any suspected occurrence of false positive or false negative results and significant deviations from the established performance characteristics of the Cue COVID-19 test of which they become aware.

All operators using the Cue COVID-19 test must be able to perform and interpret the test results, use appropriate personal protective equipment, and use the product in accordance with the authorized labeling.

Authorized laboratories using the Cue COVID-19 test must ensure that any records associated with this EUA are maintained until otherwise notified by the FDA. Such records will be made available to the FDA for inspection upon request.

The above information is for informational purposes. Please also confirm your legal obligations within your organization

What is the reimbursement CPT® code?
The reimbursement CPT code for Cue’s COVID-19 test may be: 87635 — Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrom e coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19])

The coding information contained here is for informational purposes only, and is not a guarantee of coverage or reimbursement for any product or service.

How many Cue Readers can be connected to one compatible device?
Up to six (6) Cue Readers can connect to a compatible device. To connect additional Readers, follow the simple instructions below:
  1. When logged into your Cue Account, access the “Dashboard” screen by tapping on the home button at the bottom of the screen.
  2. Tap on “Manage Readers”.
  3. Confirm that the BLUETOOTH wireless technology of your mobile device is enabled.
  4. Tap on “+”.
  5. Follow on-screen instructions to pair the additional Cue Reader. The Cue Reader is now paired to the mobile device.
Please see the Cue Health Monitoring System User Manual for further details.
What's new with Cue?
Sign up to learn about special offers, new releases, and more.
By submitting this form you agree that your email will be used in accordance with the Cue Health Website Privacy Policy. You can opt out of Cue communications at any time by clicking on the unsubscribe link at the bottom of each communication.
You're on the list